LON:AGL ANGLE (AGL) Share Price, News & Analysis → Don’t fall for the S&P’s trick today (From WealthPress) (Ad) Free AGL Stock Alerts GBX 19.25 -0.25 (-1.28%) (As of 05/24/2024 ET) Add Compare Share Share Today's Range 18.55▼ 19.5050-Day Range 11.75▼ 23.5052-Week Range 9.07▼ 37.40Volume366,342 shsAverage Volume3.05 million shsMarket Capitalization£50.16 millionP/E RatioN/ADividend Yield1.12%Price TargetGBX 70 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades Get ANGLE alerts: Email Address ANGLE MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside263.6% UpsideGBX 70 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.67 out of 5 stars 3.5 Analyst's Opinion Consensus RatingANGLE has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageANGLE has only been the subject of 1 research reports in the past 90 days.Read more about ANGLE's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for AGL. Previous Next 0.8 Dividend Strength Dividend YieldANGLE pays a meaningful dividend of 1.12%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthANGLE does not have a long track record of dividend growth.Read more about ANGLE's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AGL. Previous Next 3.1 News and Social Media Coverage News SentimentANGLE has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for ANGLE this week, compared to 0 articles on an average week.Search Interest4 people have searched for AGL on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added ANGLE to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ANGLE insiders have not sold or bought any company stock.Percentage Held by Insiders10.74% of the stock of ANGLE is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 27.22% of the stock of ANGLE is held by institutions.Read more about ANGLE's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of ANGLE is -213.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ANGLE is -213.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioANGLE has a P/B Ratio of 1.60. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsMemorial Day Sale! Get 90% OFF Behind the Markets!Today, I'm offering you the chance to receive a PLATINUM BTM subscription for up to 90% OFF! If you want to see just how much your mystery discount is...You can UNCOVER YOUR MYSTERY DISCOUNT HERE! About ANGLE Stock (LON:AGL)ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.Read More AGL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AGL Stock News HeadlinesMay 19, 2024 | americanbankingnews.comANGLE (LON:AGL) Shares Down 8.9% May 18, 2024 | msn.comUp 79% in a month, is Angle a penny stock worth considering?May 12, 2024 | msn.comIs it time to do a 360 degree u-turn and buy this penny stock?May 4, 2024 | thetimes.co.ukAstraZeneca contract puts Angle in spotlightMay 3, 2024 | lse.co.ukCORRECT: Angle shares up on assay development deal with AstraZenecaApril 10, 2024 | proactiveinvestors.com.auAngle and BioView to showcase novel breast cancer asset at AACR meetingMarch 19, 2024 | bbc.co.ukAngles, lines and polygons - EdexcelMarch 14, 2024 | afr.comHow this Deloitte auditor got his chance to rescue AGL as CEOMarch 7, 2024 | finance.yahoo.comHere's Why We're Watching ANGLE's (LON:AGL) Cash Burn SituationFebruary 29, 2024 | msn.comVIDEO: Aerial views show devastation across Central Ohio following tornado outbreakFebruary 10, 2024 | afr.com‘Qantas effect’ hangs over profit season as margins surpriseJanuary 22, 2024 | finance.yahoo.comAngle PLC Announces Potential Utility in Precision OncologyJanuary 15, 2024 | msn.comWhat’s happening with the Angle (AGL) share priceJanuary 11, 2024 | msn.com2 penny stocks I’d love to buy for my Stocks & Shares ISA today!January 5, 2024 | proactiveinvestors.comANGLE CEO says latest cancer results "may turn out to be groundbreaking"January 4, 2024 | finance.yahoo.comAngle PLC Announces Breakthrough Clinical ResultsJanuary 2, 2024 | markets.businessinsider.comANGLE Plc Signs Contract With Eisai - Quick FactsJanuary 2, 2024 | finance.yahoo.comAngle PLC - Contract announcement with Eisai Inc.December 12, 2023 | finance.yahoo.comInsider Buyers Lose Additional UK£35k As ANGLE Dips To UK£29mDecember 11, 2023 | finance.yahoo.comAngle PLC Announces Parsortix Unlocks Opportunities for Drug DiscoveryDecember 11, 2023 | finance.yahoo.comAngle PLC Announces Broker AnnouncementDecember 7, 2023 | bbc.co.ukAngles and trianglesDecember 5, 2023 | finance.yahoo.comANGLE launches Portrait+ CTC kit at SABCSDecember 5, 2023 | proactiveinvestors.comANGLE unveils new detailed cancer diagnosticNovember 17, 2023 | bbc.co.ukCritical angle and total internal reflection - Higher - CCEASee More Headlines Receive AGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings1/30/2020Today5/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolLON:AGL CUSIPN/A CIKN/A Webwww.angleplc.com Phone+44-1483-685830FaxN/AEmployees173Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 70 High Stock Price TargetGBX 70 Low Stock Price TargetGBX 70 Potential Upside/Downside+263.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)GBX (0.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-22,280,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-69.68% Return on Assets-38.07% Debt Debt-to-Equity Ratio14.26 Current Ratio7.51 Quick Ratio6.18 Sales & Book Value Annual Sales£1.82 million Price / Sales27.56 Cash FlowGBX 3.32 per share Price / Cash Flow5.80 Book ValueGBX 12 per share Price / Book1.60Miscellaneous Outstanding Shares260,580,000Free FloatN/AMarket Cap£50.16 million OptionableNot Optionable Beta0.10 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Andrew David William Newland ACA (Age 63)Meng, Founder, CEO & Executive Director Comp: $264kMr. Ian Francis Griffiths ACA (Age 60)BA, CFO, Finance Director, Company Secretary & Executive Director Comp: $164kMr. Martin Cooke (Age 55)Director of Operations & Regulatory Affairs Dr. Karen Miller Ph.D.Chief Scientific OfficerMr. Andrew John Holder (Age 56)Head of Investor Relations Ms. Anne-Sophie Pailhes-JimenezHead of R&D and Senior DirectorMr. Brett SwansigerChief Commercial OfficerMr. Nick ClaxtonSenior Vice President of Commercial OperationsMore ExecutivesKey CompetitorsVerici DxLON:VRCIYourgene HealthLON:YGENGENinCodeLON:GENIAbingdon HealthLON:ABDXDiaceuticsLON:DXRXView All Competitors AGL Stock Analysis - Frequently Asked Questions Should I buy or sell ANGLE stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ANGLE in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AGL shares. View AGL analyst ratings or view top-rated stocks. What is ANGLE's stock price target for 2024? 1 brokers have issued 1-year price targets for ANGLE's shares. Their AGL share price targets range from GBX 70 to GBX 70. On average, they expect the company's stock price to reach GBX 70 in the next twelve months. This suggests a possible upside of 263.6% from the stock's current price. View analysts price targets for AGL or view top-rated stocks among Wall Street analysts. How have AGL shares performed in 2024? ANGLE's stock was trading at GBX 11.75 at the beginning of 2024. Since then, AGL stock has increased by 63.8% and is now trading at GBX 19.25. View the best growth stocks for 2024 here. How were ANGLE's earnings last quarter? ANGLE plc (LON:AGL) announced its earnings results on Thursday, January, 30th. The company reported ($3.33) earnings per share for the quarter. What other stocks do shareholders of ANGLE own? Based on aggregate information from My MarketBeat watchlists, some companies that other ANGLE investors own include Yamana Gold (YRI), Asiamet Resources (ARS), Dekel Agri-Vision (DKL), Eldorado Gold (ELD), Polo Resources (POL), Silvercorp Metals (SVM), First Majestic Silver (AG), AFPO.L (AFPO), Ariana Resources (AAU) and Alamos Gold (AGI). How do I buy shares of ANGLE? Shares of AGL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:AGL) was last updated on 5/25/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThis could mean the end of the U.S dollar…Colonial MetalsVIPs Only (Do NOT Share This)Profits Run[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaWrite this ticker symbol down…StocksToTrade$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyA personal note from Behind The Markets' CEO Dylan Jovine...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANGLE plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.